Video

Fecal Microbiota Transplantation Now and in the Future

Author(s):

For patients with C. difficile infection, fecal micriobiota transplantation may be their best bet when medication is not effective. Even as transplant becomes a more accepted approach for treating C. diff infection, researchers are investigating other areas it can be applied to.

For patients with C. difficile infection, fecal micriobiota transplantation may be their best bet when medication is not effective. Even as transplant becomes a more accepted approach for treating C. diff infection, researchers are investigating other areas it can be applied to.

Zain Kassam, MD, MPH, FRCPC, the Chief Medical Officer for OpenBiome discussed how the treatment is applied in treatment now, how it is viewed by the US Food and Drug Administration, and how it might be used in the future during Digestive Disease Week 2015 in Washington, DC.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
© 2024 MJH Life Sciences

All rights reserved.